Application of Serum Levels of CEA, CA19-9 and CA72-4 in Diagnosing Colorectal Cancer

何穗,李登清,李绍杰,李文凯
DOI: https://doi.org/10.3969/j.issn.1005-8982.2004.18.021
2004-01-01
Abstract:Objective: To investigate the application of CEA, CA19-9 and CA72-4 in diagnosing colorectal cancer and use their appropriate combination to raise the sensitivity in detecting the cancer. Methods: Three tumor markers of 56 patients with colorectal cancer and 30 healthy adult were detected by electrochemiluminescence assays. Results: CEA, CA19-9 and CA72-4 levels of the healthy group were (2.52±1.90)μg/L, (11.12±7.35) ng/ml, (3.27±2.70) ng/ml. The serum levels of CEA, CA19-9 and CA72-4 were significantly higher in patients with colorectal cancer (Dukes B, C, D) than in the healthy group (P0.05), and their sensitivity increased with the Dukes stage. The sensitivity of combined use of CEA and CA72-4 and combined use of CEA, CA19-9 and CA72-4 were 66.1%, 67.9%, which were significantly higher than any of the single tumor markers. Conclusion: Appropriate combinations of tumor markers may raise their sensitivity in diagnosing colorectal cancer. Among them, the combination of CEA and CA72-4 is the best.
What problem does this paper attempt to address?